Download PDF
Thromb Haemost 1987; 57(03): 361-371
DOI: 10.1055/s-0038-1651134
International Committee Communications
Schattauer GmbH Stuttgart

ICTH - Subcommittee on Clinical Trials: Registry of Multicenter Clinical Trials: Eighth Report - 1986

J P Boissel
The Unité de Pharmacologie Clinique, Hôpital Neuro-Cardiologique, Lyon, France
› Author Affiliations
Further Information

Publication History

Received 14 January 1987

Accepted after revision 01 February 1987

Publication Date:
06 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Verstraete M. Registry of prospective clinical trials. First report. Thrombos Diathes Haemorrh 1975; 33: 655-663
    PubMedGoogle Scholar
  • 2 Verstraete M. Registry of prospective clinical trials. Second report. Thromb Haemostas 1976; 36: 239-250
    PubMedGoogle Scholar
  • 3 Verstraete M. Registry of prospective clinical trials. Third report. Thromb Haemostas 1978; 39: 759-767
    PubMedGoogle Scholar
  • 4 Verstraete M. Registry of prospective clinical trials. Fourth report. Thromb Haemostas 1980; 43: 176-181
    PubMedGoogle Scholar
  • 5 Verstraete M. Registry of prospective clinical trials. Fifth report. Thromb Haemostas 1982; 48: 334-338
    PubMedGoogle Scholar
  • 6 Verstraete M. Registry of prospective clinical trials. Sixth report. Thromb Haemostas 1984; 51: 283-290
    PubMedGoogle Scholar
  • 7 Boissel J-P. Registry of prospective clinical trials. Seventh report. Thromb Haemostas 1986; 55: 282-291
    PubMedGoogle Scholar
  • 8 GISSI Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1985; I: 397-401
    PubMedGoogle Scholar
  • 9 ISAM Study Group Prospective placebo-controlled double-blind multicenter trial of intravenous streptokinase in acute myocardial infarction (ISAM): results on 21-day-mortality, morbidity and infarct size. NEJM 1986; 314: 1465-1471
    CrossrefPubMedGoogle Scholar
  • 10 Gold HK, Leinbach RC, Garabedian HD, Yasuda T, Johns JA, Grossbach EB, Palacios I, Collen D. Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. Circulation 1986; 73: 347-352
    CrossrefPubMedGoogle Scholar
  • 11 Simoons ML, Serruys PW, v/d Brand M, Bär F, de Zwaan C, Res J, Verheugt F WA, Krauss XH, Remme WJ, Vermeer F, Lubsen J. Improved survival after early thrombolysis in acute myocardial infarction; a randomised trial by the Interuniversity Cardiology Institute in the Netherlands. Lancet 1985; III: 578-581
    PubMedGoogle Scholar
  • 12 Lewis HD, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE, Schnaper HW, LeWinter MM, Linares E, Pouget JM, Sabharwal SC, Chesler E, DeMots H. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. NEJM 1983; 309: 396-403
    CrossrefPubMedGoogle Scholar
  • 13 Cairns JA, Gent M, Singer J, Finnie KJ, Froggatt GM, Holder DA, Jablonsky G, Kostuk WJ, Melendez LJ, Myers MG, Sackett DL, Sealey BJ, Tanser PH. Aspirin, sulfinpyrazone, or both in unstable angina. NEJM 1985; 313: 1369-1375
    CrossrefPubMedGoogle Scholar
  • 14 Kakkar VV, Murray W JG. Efficacy and safety of low-molecular-weight heparin (CY 216) in preventing post-operative venous thromboembolism: a cooperative study. Br J Surg 1985; 72: 786-791
    CrossrefPubMedGoogle Scholar
  • 15 Turpie A GG, Levine MN, Hirsh J, Carter CJ, Jay RM, Powers PJ, Andrew M, Hull RD, Gent M. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. NEJM 1986; 315: 925-929
    CrossrefPubMedGoogle Scholar
  • 16 De Feudis FV. “Calcium-antagonists” and atherosclerosis; basic studies and therapeutic implications. Life Sciences 1983; 32: 557-563
    CrossrefPubMedGoogle Scholar